世界の臨床試験機器・補助ソリューション市場規模は、予測期間中に8.2%のCAGRで拡大し、2028年には44億USドルに達する見込みです。製薬・医療分野の成長、臨床試験のグローバル化、研究開発費の増加などが市場を牽引する要因となっています。
近年、臨床試験の手順は大幅に進化しています。複雑な臨床試験は、ヘルスケアのサプライチェーン全体で新たな問題を引き起こしています。最近の臨床試験では、膨大な数の患者や患者のサブグループ、さらには多数の国や研究施設が関与することが多くなっています。その結果、サプライチェーン・マネージャーが臨床試験機器や付属品を扱う際に直面する課題の数は増加しています。医療機器をレンタルすることで、保管・回収・廃棄の負担を軽減することができます。もう一つの重要な決定理由は、機器をレンタルすることで、認可された臨床試験施設を用意するための多額の初期費用や多額の投資を削減できることです。
COVID-19のパンデミックが世界市場に影響を与え、その結果、機器・補助用品のサプライチェーンが減速しました。COVID-19のパンデミックは、臨床試験の環境に大きな変化をもたらしました。パンデミック前に行われていた何百もの実験が中止された一方で、効果的な治療法や介入法を探すために多くの新しい実験が開始されました。COVID-19は臨床試験のあり方を変え、医療のデジタル化や最先端の技術・手法の導入を促しました。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Product
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1:
1.10.2 Objective - 2:
1.10.3 Objective - 3:
1.10.4 Objective - 4:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Evolving Clinical Trials Needs
3.3.1.2 Rising investment in R&D
3.3.1.3 Growing pharmaceutical & Medical Devices industry
3.3.2 Market Restraint Analysis
3.3.2.1 Rising Cost of Clinical Trials
3.4 Porter’s Five Forces Analysis
3.5 PESTEL Analysis
3.6 Major Deals & Strategic Alliances Analysis
3.7 COVID Impact Analysis
3.8 Clinical Trial Equipment & Ancillary Solutions Market: Total Addressable Market (TAM) Analysis
Chapter 4 Clinical Trial Equipment & Ancillary Solutions Market: Product Segment Analysis
4.1 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis, 2020 & 2028
4.2 Sourcing
4.2.1 Sourcing Market, 2016 - 2028 (USD Million)
4.2.2 Procurement
4.2.2.1 ProcureMent market, 2016 - 2028 (USD Million)
4.2.2.2 Equipment
4.2.2.2.1 Equipment market, 2016 - 2028 (USD Million)
4.2.2.2.2 Ancillaries
4.2.2.2.2.1 Ancillaries market, 2016 - 2028 (USD Million)
4.2.3 Rental
4.2.3.1 Rental market, 2016 - 2028 (USD Million)
4.2.3.2 Equipment
4.2.3.2.1 Equipment market, 2016 - 2028 (USD Million)
4.2.3.3 Ancillaries
4.2.3.3.1 Ancillaries market, 2016 - 2028 (USD Million)
4.3 Supply/Logistics
4.3.1 Supply/Logistics market, 2016 - 2028 (USD Million)
4.3.2 Transportation
4.3.2.1 Transportation market, 2016 - 2028 (USD Million)
4.3.3 Packaging
4.3.3.1 Packaging market, 2016 - 2028 (USD Million)
4.3.4 Others
4.3.4.1 Others market, 2016 - 2028 (USD Million)
4.4 Service
4.4.1 Service Market, 2016 - 2028 (USD Million)
4.4.2 Calibration
4.4.2.1 Calibration market, 2016 - 2028 (USD Million)
4.4.3 Equipment Servicing
4.4.3.1 Equipment Servicing market, 2016 - 2028 (USD Million)
4.4.4 Others
4.4.4.1 Others market, 2016 - 2028 (USD Million)
4.5 Others
4.5.1 Others Market, 2016 - 2028 (USD Million)
Chapter 5 Clinical Trial Equipment & Ancillary Solutions Market: Phase Segment Analysis
5.1 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis, 2020 & 2028
5.2 Phase I
5.2.1 Phase I Market, 2016 - 2028 (USD Million)
5.3 Phase II
5.3.1 Phase II Market, 2016 - 2028 (USD Million)
5.4 Phase III
5.4.1 Phase III Market, 2016 - 2028 (USD Million)
5.5 Phase IV
5.5.1 Phase IV Market, 2016 - 2028 (USD Million)
Chapter 6 Clinical Trial Equipment & Ancillary Solutions Market: Regional Analysis
6.1 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis, 2020 & 2028
6.2 North America
6.2.1 North America Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.2.2 The U.S.
6.2.2.1 The U.S. Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.3 Europe
6.3.1 Europe Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.3.2 The U.K.
6.3.2.1 The U.K. Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.3.4 France
6.3.4.1 France Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.3.5 Italy
6.3.5.1 Italy Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.3.6 Spain
6.3.6.1 Spain Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.4.2 India
6.4.2.1 India Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.4.3 Japan
6.4.3.1 Japan Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.4.4 China
6.4.4.1 China Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.4.5 Australia
6.4.5.1 Australia Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.5 Latin America
6.5.1 Latin America Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.5.5 Colombia
6.5.5.1 Colombia Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.6 MEA
6.6.1 MEA Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
6.6.4 UAE
6.6.4.1 UAE Clinical Trial Equipment & Ancillary Solutions market, 2016 - 2028 (USD Million)
Chapter 7 Company Profiles
7.1 Company Profiles
7.1.1 Ancillare LP
7.1.1.1 Company overview
7.1.1.2 Service benchmarking
7.1.1.3 Strategic initiatives
7.1.2 Imperial CRS
7.1.2.1 Company overview
7.1.2.2 Service benchmarking
7.1.3 Woodley Equipment Company Ltd
7.1.3.1 Company overview
7.1.3.2 Service benchmarking
7.1.3.3 Strategic initiatives
7.1.4 Thermo Fisher Scientific Inc.
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 PPD, Inc
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Product benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Parexel International Corporation
7.1.6.1 Company overview
7.1.6.2 Product benchmarking
7.1.6.3 Strategic initiatives
7.1.7 MediCapital Rent
7.1.7.1 Company overview
7.1.7.2 Product benchmarking
7.1.8 Quipment SAS
7.1.8.1 Company overview
7.1.8.2 Product benchmarking
7.1.9 IRM
7.1.9.1 Company overview
7.1.9.2 Product benchmarking
7.1.10 MARKEN A UPS COMPANy
7.1.10.1 Company overview
7.1.10.2 Product benchmarking
7.1.10.3 Strategic initiatives
7.1.11 MYONEX
7.1.11.1 Company overview
7.1.11.2 Product benchmarking
7.1.12 Yourway
7.1.12.1 Company overview
7.1.12.2 Product benchmarking
7.1.12.3 Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 List of secondary sources
Table 3 Global clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 4 Global clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 5 Global clinical trial equipment & ancillary solutions market, by region, 2016 - 2028 (USD Million)
Table 6 North America clinical trial equipment & ancillary solutions market, by country, 2016 - 2028 (USD Million)
Table 7 North America clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 8 North America clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 9 The U.S. clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 10 The U.S. clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 11 Canada clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 12 Canada clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 13 Europe clinical trial equipment & ancillary solutions market, by country, 2016 - 2028 (USD Million)
Table 14 Europe clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 15 Europe clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 16 The U.K. clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 17 The U.K. clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 18 Germany clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 19 Germany clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 20 Spain clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 21 Spain clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 22 France clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 23 France clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 24 Italy clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 25 Italy clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 26 Asia Pacific clinical trial equipment & ancillary solutions market, by country, 2016 - 2028 (USD Million)
Table 27 Asia Pacific clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 28 Asia Pacific clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 29 China clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 30 China clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 31 India clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 32 India clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 33 Japan clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 34 Japan clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 35 Australia clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 36 Australia clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 37 South Korea clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 38 South Korea clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 39 Latin America clinical trial equipment & ancillary solutions market, by country, 2016 - 2028 (USD Million)
Table 40 Latin America clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 41 Latin America clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 42 Brazil clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 43 Brazil clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 44 Mexico clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 45 Mexico clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 46 Argentina clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 47 Argentina clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 46 Colombia clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 47 Colombia clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 48 MEA clinical trial equipment & ancillary solutions market, by country, 2016 - 2028 (USD Million)
Table 49 MEA clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 50 MEA clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 51 South Africa clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 52 South Africa clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 53 Saudi Arabia clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 54 Saudi Arabia clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
Table 55 UAE clinical trial equipment & ancillary solutions market, by product, 2016 - 2028 (USD Million)
Table 56 UAE clinical trial equipment & ancillary solutions market, by phase, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Clinical trial equipment & ancillary solutions snapshot (2020)
Fig. 9 Clinical trial equipment & ancillary solutions market segmentation
Fig. 10 Clinical trial equipment & ancillary solutions market: Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Companies with affected trials, by size
Fig. 19 Affected trials, by study phase
Fig. 20 Clinical trial equipment & ancillary solutions market product: Segment dashboard
Fig. 21 Clinical trial equipment & ancillary solutions market: Product movement analysis
Fig. 22 Sourcing market, 2016 - 2028 (USD Million)
Fig. 23 Procurement market, 2016 - 2028 (USD Million)
Fig. 24 Rental market, 2016 - 2028 (USD Million)
Fig. 25 Supply/Logistics market, 2016 - 2028 (USD Million)
Fig. 26 Transportation market, 2016 - 2028 (USD Million)
Fig. 27 Packaging market, 2016 - 2028 (USD Million)
Fig. 28 Others market, 2016 - 2028 (USD Million)
Fig. 29 Service market, 2016 - 2028 (USD Million)
Fig. 30 Calibrations market, 2016 - 2028 (USD Million)
Fig. 31 Equipment servicing market, 2016 - 2028 (USD Million)
Fig. 32 Others market, 2016 - 2028 (USD Million)
Fig. 33 Others market, 2016 - 2028 (USD Million)
Fig. 34 Clinical trial equipment & ancillary solutions market phase outlook: Segment dashboard
Fig. 35 Clinical trial kits market: Phase movement analysis
Fig. 36 Phase I market, 2016 - 2028 (USD Million)
Fig. 37 Phase II market, 2016 - 2028 (USD Million)
Fig. 38 Phase III market, 2016 - 2028 (USD Million)
Fig. 39 Phase IV market, 2016 - 2028 (USD Million)
Fig. 40 Regional market: Key takeaways
Fig. 41 Regional outlook, 2020 2028
Fig. 42 North America market, 2016 - 2028 (USD Million)
Fig. 43 The U.S. market, 2016 - 2028 (USD Million)
Fig. 44 Canada market, 2016 - 2028 (USD Million)
Fig. 45 Europe market, 2016 - 2028 (USD Million)
Fig. 46 The U.K. market, 2016 - 2028 (USD Million)
Fig. 47 Germany market, 2016 - 2028 (USD Million)
Fig. 48 France market, 2016 - 2028 (USD Million)
Fig. 49 Italy market, 2016 - 2028 (USD Million)
Fig. 50 Spain market, 2016 - 2028 (USD Million)
Fig. 51 Asia Pacific market, 2016 - 2028 (USD Million)
Fig. 52 Japan market, 2016 - 2028 (USD Million)
Fig. 53 China market, 2016 - 2028 (USD Million)
Fig. 54 India market, 2016 - 2028 (USD Million)
Fig. 55 Australia market, 2016 - 2028 (USD Million)
Fig. 56 South Korea market, 2016 - 2028 (USD Million)
Fig. 57 Latin America market, 2016 - 2028 (USD Million)
Fig. 58 Brazil market, 2016 - 2028 (USD Million)
Fig. 59 Mexico market, 2016 - 2028 (USD Million)
Fig. 60 Argentina market, 2016 - 2028 (USD Million)
Fig. 61 Colombia market, 2016 - 2028 (USD Million)
Fig. 62 MEA market, 2016 - 2028 (USD Million)
Fig. 63 South Africa market, 2016 - 2028 (USD Million)
Fig. 64 Saudi Arabia market, 2016 - 2028 (USD Million)
Fig. 65 UAE market, 2016 - 2028 (USD Million)
